R&D Catching the signals sooner: AI’s role in proactive pharmaco... AI is not a replacement for medical judgement. Rather, it enables a human-guided, scientifically grounded approach.
News FDA won't approve Summit, Akeso's ivonescimab The FDA has said it cannot approve Summit /Akeso's ivonescimab, delaying a drug that could usher in a new era of dual-acting cancer immunotherapies.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.